Lipidomimetic compounds act as HIV-1 entry inhibitors by altering viral membrane structure

The envelope of Human Immunodeficiency Virus type 1 (HIV-1) consists of a liquid-ordered membrane enriched in raft lipids and containing the viral glycoproteins. Previous studies demonstrated that changes in viral membrane lipid composition affecting membrane structure or curvature can impair infect...

Full description

Saved in:
Bibliographic Details
Main Authors: Nieto-Garai, Jon Ander (Author) , Glass, Bärbel (Author) , Börner, Kathleen (Author) , Kräusslich, Hans-Georg (Author)
Format: Article (Journal)
Language:English
Published: 04 September 2018
In: Frontiers in immunology
Year: 2018, Volume: 9
ISSN:1664-3224
DOI:10.3389/fimmu.2018.01983
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.3389/fimmu.2018.01983
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fimmu.2018.01983/full
Get full text
Author Notes:Jon Ander Nieto-Garai, Bärbel Glass, Carmen Bunn, Matthias Giese, Gary Jennings, Beate Brankatschk, Sameer Agarwal, Kathleen Börner, F. Xabier Contreras, Hans-Joachim Knölker, Claudia Zankl, Kai Simons, Cornelia Schroeder, Maier Lorizate and Hans-Georg Kräusslich

MARC

LEADER 00000caa a2200000 c 4500
001 1581627904
003 DE-627
005 20210815222727.0
007 cr uuu---uuuuu
008 181008s2018 xx |||||o 00| ||eng c
024 7 |a 10.3389/fimmu.2018.01983  |2 doi 
035 |a (DE-627)1581627904 
035 |a (DE-576)511627904 
035 |a (DE-599)BSZ511627904 
035 |a (OCoLC)1264007012 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Nieto-Garai, Jon Ander  |e VerfasserIn  |0 (DE-588)116860530X  |0 (DE-627)1032367857  |0 (DE-576)511627491  |4 aut 
245 1 0 |a Lipidomimetic compounds act as HIV-1 entry inhibitors by altering viral membrane structure  |c Jon Ander Nieto-Garai, Bärbel Glass, Carmen Bunn, Matthias Giese, Gary Jennings, Beate Brankatschk, Sameer Agarwal, Kathleen Börner, F. Xabier Contreras, Hans-Joachim Knölker, Claudia Zankl, Kai Simons, Cornelia Schroeder, Maier Lorizate and Hans-Georg Kräusslich 
264 1 |c 04 September 2018 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.10.2018 
520 |a The envelope of Human Immunodeficiency Virus type 1 (HIV-1) consists of a liquid-ordered membrane enriched in raft lipids and containing the viral glycoproteins. Previous studies demonstrated that changes in viral membrane lipid composition affecting membrane structure or curvature can impair infectivity. Here, we describe novel antiviral compounds that were identified by screening compound libraries based on raft lipid-like scaffolds. Three distinct molecular structures were chosen for mode-of-action studies, a sterol derivative (J391B), a sphingosine derivative (J582C) and a long aliphatic chain derivative (IBS70). All three target the viral membrane and inhibit virus infectivity at the stage of fusion without perturbing virus stability or affecting virion-associated envelope glycoproteins. Their effect did not depend on the expressed envelope glycoproteins or a specific entry route, being equally strong in HIV pseudotypes carrying VSV-G or MLV-Env glycoproteins. Labelling with laurdan, a reporter of membrane order, revealed different membrane structure alterations upon compound treatment of HIV-1, which correlated with loss of infectivity. J582C and IBS70 decreased membrane order in distinctive ways, whereas J391B increased membrane order. The compounds’ effects on membrane order were reproduced in liposomes generated from extracted HIV lipids and thus independent both of virion proteins and of membrane leaflet asymmetry. Remarkably, increase of membrane order by J391B required phosphatidylserine, a lipid enriched in the HIV envelope. Counterintuitively, mixtures of two compounds with opposite effects on membrane order, J582C and J391B, did not neutralize each other but synergistically inhibited HIV infection. Thus, altering membrane order, which can occur by different mechanisms, constitutes a novel antiviral mode of action that may be of general relevance for enveloped viruses and difficult to overcome by resistance development. 
650 4 |a HIV Fusion Inhibitors 
650 4 |a HIV-1 envelope 
650 4 |a Laurdan 
650 4 |a lipid raft modulation 
650 4 |a Lipidomimetics 
650 4 |a Membrane order 
650 4 |a phosphatidylserine 
700 1 |a Glass, Bärbel  |e VerfasserIn  |0 (DE-588)102760031X  |0 (DE-627)729455165  |0 (DE-576)373447884  |4 aut 
700 1 |a Börner, Kathleen  |e VerfasserIn  |0 (DE-588)1030276382  |0 (DE-627)734977727  |0 (DE-576)378068806  |4 aut 
700 1 |a Kräusslich, Hans-Georg  |d 1958-  |e VerfasserIn  |0 (DE-588)1027601782  |0 (DE-627)729459004  |0 (DE-576)373450524  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in immunology  |d Lausanne : Frontiers Media, 2010  |g 9(2018), Artikel-ID 1983  |h Online-Ressource  |w (DE-627)657998354  |w (DE-600)2606827-8  |w (DE-576)343624834  |x 1664-3224  |7 nnas  |a Lipidomimetic compounds act as HIV-1 entry inhibitors by altering viral membrane structure 
773 1 8 |g volume:9  |g year:2018  |g elocationid:1983  |g extent:18  |a Lipidomimetic compounds act as HIV-1 entry inhibitors by altering viral membrane structure 
856 4 0 |u http://dx.doi.org/10.3389/fimmu.2018.01983  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fimmu.2018.01983/full  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20181008 
993 |a Article 
994 |a 2018 
998 |g 1027601782  |a Kräusslich, Hans-Georg  |m 1027601782:Kräusslich, Hans-Georg  |d 910000  |d 911700  |e 910000PK1027601782  |e 911700PK1027601782  |k 0/910000/  |k 1/910000/911700/  |p 15  |y j 
998 |g 1030276382  |a Börner, Kathleen  |m 1030276382:Börner, Kathleen  |d 910000  |d 911700  |e 910000PB1030276382  |e 911700PB1030276382  |k 0/910000/  |k 1/910000/911700/  |p 8 
998 |g 102760031X  |a Glass, Bärbel  |m 102760031X:Glass, Bärbel  |d 910000  |d 911700  |e 910000PG102760031X  |e 911700PG102760031X  |k 0/910000/  |k 1/910000/911700/  |p 2 
999 |a KXP-PPN1581627904  |e 3028043343 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Lipidomimetic compounds act as HIV-1 entry inhibitors by altering viral membrane structure","title_sort":"Lipidomimetic compounds act as HIV-1 entry inhibitors by altering viral membrane structure"}],"note":["Gesehen am 08.10.2018"],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"04 September 2018"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"language":["eng"],"part":{"volume":"9","text":"9(2018), Artikel-ID 1983","extent":"18","year":"2018"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"657998354","id":{"zdb":["2606827-8"],"issn":["1664-3224"],"eki":["657998354"]},"note":["Gesehen am 07.11.13"],"origin":[{"publisherPlace":"Lausanne","publisher":"Frontiers Media","dateIssuedKey":"2010","dateIssuedDisp":"2010-"}],"pubHistory":["1.2010 -"],"title":[{"title":"Frontiers in immunology","title_sort":"Frontiers in immunology"}],"disp":"Lipidomimetic compounds act as HIV-1 entry inhibitors by altering viral membrane structureFrontiers in immunology","type":{"media":"Online-Ressource","bibl":"periodical"}}],"recId":"1581627904","physDesc":[{"extent":"18 S."}],"name":{"displayForm":["Jon Ander Nieto-Garai, Bärbel Glass, Carmen Bunn, Matthias Giese, Gary Jennings, Beate Brankatschk, Sameer Agarwal, Kathleen Börner, F. Xabier Contreras, Hans-Joachim Knölker, Claudia Zankl, Kai Simons, Cornelia Schroeder, Maier Lorizate and Hans-Georg Kräusslich"]},"id":{"doi":["10.3389/fimmu.2018.01983"],"eki":["1581627904"]},"person":[{"display":"Nieto-Garai, Jon Ander","family":"Nieto-Garai","role":"aut","given":"Jon Ander"},{"family":"Glass","display":"Glass, Bärbel","given":"Bärbel","role":"aut"},{"display":"Börner, Kathleen","family":"Börner","given":"Kathleen","role":"aut"},{"display":"Kräusslich, Hans-Georg","family":"Kräusslich","given":"Hans-Georg","role":"aut"}],"language":["eng"]} 
SRT |a NIETOGARAILIPIDOMIME0420